News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Braunstein Scott
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/08/2023 |
4
| Braunstein Scott (CHAIRMAN AND CEO) has filed a Form 4 on MARINUS PHARMACEUTICALS, INC.|
Txns:
| Sold 6,413 shares
@ $9.55, valued at
$61.2k
Sold 30 shares
@ $8.94, valued at
$268.2 |
|
| 02/23/2023 |
4
| Braunstein Scott (Director) has filed a Form 4 on Caribou Biosciences, Inc.|
Txns:
| Granted 21,500 options to buy
@ $6.12, valued at
$131.6k
|
|
| 01/30/2023 |
4
| Braunstein Scott (CHAIRMAN AND CEO) has filed a Form 4 on MARINUS PHARMACEUTICALS, INC.|
Txns:
| Granted 80,000 shares
@ $0
Granted 360,000 options to buy
@ $5.94, valued at
$2.1M
|
|
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2021 |
4
| Braunstein Scott (Director) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC|
Txns:
| Disposed/sold 13,171 options to buy
@ $33.57, valued at
$442.2k
Disposed/sold 26,342 options to buy
@ $10.81, valued at
$284.8k
Disposed/sold 13,171 options to buy
@ $37.52, valued at
$494.2k
|
|
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2020 |
4
| Braunstein Scott (Director) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Granted 9,000 options to buy
@ $35, valued at
$315k
|
|
| 06/08/2020 |
4
| Braunstein Scott (Director) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC|
Txns:
| Granted 13,171 options to buy
@ $37.52, valued at
$494.2k
|
|
| 05/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2020 |
4
| Braunstein Scott (Director) has filed a Form 4 on ArTara Therapeutics, Inc.|
Txns:
| Granted 26,500 shares
@ $0
Granted 9,537 options to buy
@ $9.18, valued at
$87.5k
Granted 2,861 options to buy
@ $9.18, valued at
$26.3k
Granted 6,676 options to buy
@ $9.18, valued at
$61.3k
Granted 15,737 options to buy
@ $9.18, valued at
$144.5k
|
|
| 01/10/2020 |
4
| Braunstein Scott (CEO) has filed a Form 4 on MARINUS PHARMACEUTICALS INC|
Txns:
| Granted 1,800,000 options to buy
@ $2.07, valued at
$3.7M
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2019 |
4
| Braunstein Scott (CEO) has filed a Form 4 on MARINUS PHARMACEUTICALS INC|
Txns:
| Bought 100,000 shares
@ $1.25, valued at
$125k
|
|
| 08/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2019 |
4
| Braunstein Scott (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 4,967 shares
@ $0 |
|
| 05/16/2019 |
4
| Braunstein Scott (Director) has filed a Form 4 on TREVENA INC|
Txns:
| Granted 30,000 options to buy
@ $1.34, valued at
$40.2k
|
|
| 02/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/02/2019 |
4
| Braunstein Scott (Director) has filed a Form 4 on ZIOPHARM ONCOLOGY INC|
Txns:
| Granted 126,700 options to buy
@ $1.87, valued at
$236.9k
|
|
| 10/01/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/20/2018 |
4
| Braunstein Scott (Director) has filed a Form 4 on ZIOPHARM ONCOLOGY INC|
Txns:
| Granted 50,000 options to buy
@ $3, valued at
$150k
|
|
| 05/25/2018 |
4
| Braunstein Scott (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 10,100 options to buy
@ $38.32, valued at
$387k
|
|
| 01/05/2018 |
4
| Braunstein Scott (COO) has filed a Form 4 on Pacira Pharmaceuticals, Inc.|
Txns:
| Granted 60,000 options to buy
@ $46.35, valued at
$2.8M
|
|
| 06/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/09/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/17/2016 |
4
| Braunstein Scott (SVP, Strategy & Corp. Dev.) has filed a Form 4 on Pacira Pharmaceuticals, Inc.|
Txns:
| Granted 8,750 shares
@ $0
Granted 17,500 options to buy
@ $40.34, valued at
$706k
|
|
| 06/10/2016 |
4
| Braunstein Scott (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 8,000 options to buy
@ $17.75, valued at
$142k
|
|
|
|